Combination therapy for treating, preventing or managing proliferative disorders and cancers

Details for Australian Patent Application No. 2003217961 (hide)

Owner Signal Pharmaceuticals, LLC.

Inventors Stein, Bernd M; Westwick, John K; Ennis, Bruce W

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003217961

PCT Number PCT/US03/06894

PCT Pub. Number WO2003/075917

Priority 60/362,705 08.03.02 US; 10/384,440 07.03.03 US

Filing date 7 March 2003

Wipo publication date 22 September 2003

Acceptance publication date 28 February 2008

International Classifications

C07D 231/54 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/282 (2006.01)

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/42 (2006.01) - Oxazoles

A61K 31/425 (2006.01) - Thiazoles

A61K 31/454 (2006.01)

A61K 31/4745 (2006.01)

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 31/704 (2006.01)

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/362,705 08.03.02 US; 10/384,440 07.03.03 US

30 October 2003 Application Open to Public Inspection

  Published as AU-B-2003217961

28 February 2008 Application Accepted

  Published as AU-B-2003217961

26 June 2008 Standard Patent Sealed

9 October 2008 Alteration of Name

  The name of the patentee has been altered to Signal Pharmaceuticals, LLC

30 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003217962-DETECTION OF PROTEINS INTERACTIONS

2003217960-SYSTEM AND METHOD FOR LEAK RATE TESTING DURING ADIABATIC COOLING